First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic Non-Small Cell Lung Cancer in CheckMate 9LA:3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations
| Title | First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic Non-Small Cell Lung Cancer in CheckMate 9LA:3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations |
|---|---|
| Description | The article will be published in Journal of Thoracic Oncology |
| Organism | Homo sapiens |
| Data Type | Biomarker Data |
| Data Accessibility | Controlled-access |
| BioProject | PRJCA011385 |
| Release Date | 2022-12-31 |
| Submitter | nan zhao (1165095416@qq.com) |
| Organization | Jilin Cancer Hospital |
| Submission Date | 2022-08-23 |
HTTP download speed may be slow. It is highly recommended that you download the dataset using a dedicated FTP tool (such as FileZilla Client).
| File ID | File Title | Number/Samples | File Type | File Size | File Suffix | Download Times | Download |
|---|---|---|---|---|---|---|---|
| OMIX001660-01 | CM9LA results in JTO article | 1 | Biomarker Data | 2.2 MB | zip | 0 | Controlled |